scispace - formally typeset
Open AccessJournal ArticleDOI

Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review

TLDR
Improving adherence in schizophrenia may have a considerable positive impact on patients and society by focusing on the identified multitude of factors driving nonadherence, including lack of insight, medication beliefs and substance abuse.
Abstract
Background:Nonadherence to medication is a recognized problem and may be the most challenging aspect of treatment.Methods:We performed a systematic review of factors that influence adherence and the consequences of nonadherence to the patient, healthcare system and society, in patients with schizophrenia. Particular attention was given to the effect of nonadherence on hospitalization rates, as a key driver of increased costs of care. A qualitative systematic literature review was conducted using a broad search strategy using disease and adherence terms. Due to the large number of abstracts identified, article selection was based on studies with larger sample sizes published after 2001. Thirty-seven full papers were included: 15 studies on drivers and 22 on consequences, of which 12 assessed the link between nonadherence and hospitalization.Results:Key drivers of nonadherence included lack of insight, medication beliefs and substance abuse. Key consequences of nonadherence included greater risk of relapse,...

read more

Citations
More filters
Journal ArticleDOI

The Implications of Adverse Pharmacologic Reactions and Complex Pathogenic Mechanisms in Schizophrenia

TL;DR: It is shown that the etiopathogenesis of schizophrenia accounts for a combination of genetic factors forming the genetic spectrum of vulnerability for schizophrenia, and that the pathogenic model of schizophrenia, customized for each specific case, requires a prophylactic behavior.
Journal ArticleDOI

Treatment with aripiprazole once-monthly injectable formulation is effective in improving symptoms and global functioning in schizophrenia with and without comorbid substance use – a post hoc analysis of the ReLiAM study

TL;DR: Aripiprazole once-monthly injectable formulation of Abilify Maintena (AOM) was used in the ReLiAM study as mentioned in this paper to evaluate the evolution of global functional status in patients treated with AOM for 12 months.
Journal ArticleDOI

Schizophrenic patients with type 2 diabetes: An 8-year population-based observational study

TL;DR: In this article, a realistic evaluation of the prevalence of type 2 diabetes mellitus (T2DM) among Polish schizophrenic patients who have sought treatment through the Polish National Health Fund in the years 2010-2017 was presented.
Journal ArticleDOI

A clinical risk prediction tool for identifying the risk of violent offending in severe mental illness: A retrospective case-control study.

TL;DR: Wang et al. as discussed by the authors used stepwise regression and Lasso's method to screen for predictors, built a multivariate logistic regression model, and performed internal validation with the 10- fold cross-validation to develop the final prediction model.
References
More filters
Journal ArticleDOI

The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.

TL;DR: Recommendations for addressing adherence problems to improve patient outcomes are developed, noting that multiple problems may be involved, requiring a combination of interventions.
Journal ArticleDOI

Partial Compliance and Risk of Rehospitalization Among California Medicaid Patients With Schizophrenia

TL;DR: This study showed a direct correlation between estimated partial compliance and hospitalization risk among patients with schizophrenia across a continuum of compliance behavior.
Related Papers (5)

The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.